Tech Company Financing Transactions
Scipher Medicine Funding Round
Scipher Medicine secured a Series B funding round on 12/20/2019. Backers included Northpond Ventures, Alumni Capital Network and Granpool.
Transaction Overview
Company Name
Announced On
12/20/2019
Transaction Type
Venture Equity
Amount
Unknown
Round
Series B
Investors
Northpond Ventures (Lead Investor)
Khosla Ventures (Samir Kaul)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
303 Wyman St.
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Not Recorded
Overview
Scipher Medicine is determined to ensure that patients are given access to drugs that work effectively -- from day one. Its molecular technology platform predicts accurately whether a patient will respond to a particular therapy. For patients who don't respond to existing drugs, the platform identifies new targets that can be used to develop more effective therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alif Saleh
Chief Technical Officer
Slava Akmaev
Co-Founder
Albert Barabási
Co-Founder
Joseph Loscalzo
VP - General Counsel
Jeffrey Sachs
VP - Human Resources
Alison Stowell
VP - Marketing
Jerry Conway
VP - Sales
Brian McEvilly
Browse more venture capital transactions:
Prev: 12/20/2019: Gloat venture capital transaction
Next: 12/20/2019: Leapfin venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs